Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

6.11USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$6.11
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
64,996
52-wk High
$8.97
52-wk Low
$5.07

Chart for

About

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $316.26
Shares Outstanding(Mil.): 51.76
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.07 15.47
EPS (TTM): -- -- --
ROI: -- 15.07 33.71
ROE: -- 16.57 16.38

BRIEF-Rockwell Medical Signs License Agreement With Quimica Europea To Commercialize Triferic In Peru

* ROCKWELL MEDICAL SIGNS EXCLUSIVE LICENSE AGREEMENT WITH QUIMICA EUROPEA TO COMMERCIALIZE TRIFERIC IN PERU

Dec 12 2017

BRIEF-Richmond Brothers Says On Nov 22, Entered Into Settlement And Standstill Agreement With Rockwell Medical

* RICHMOND BROTHERS INC​ SAYS ON NOVEMBER 22, ENTERED INTO SETTLEMENT AND STANDSTILL AGREEMENT WITH ROCKWELL MEDICAL INC - SEC FILING

Nov 27 2017

BRIEF-Rockwell Medical posts Q3 loss of $0.10 per share

* Q3 sales rose 14.1 percent to $14.6 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Nov 08 2017

BRIEF-ROCKWELL MEDICAL SAYS FDA REQUESTS EXTRA TIME TO REVIEW CALCITRIOL SUBMISSION

* ROCKWELL UPDATE ON CALCITRIOL POST-APPROVAL MANUFACTURING SUBMISSION TO FDA

Oct 25 2017

BRIEF-Rockwell files Calcitriol post-approval manufacturing submission with FDA

* Rockwell files Calcitriol post-approval manufacturing submission with FDA

Sep 28 2017

BRIEF-Rockwell Medical updates progress on calcitriol commercial launch

* Rockwell Medical updates progress on calcitriol commercial launch

Sep 13 2017

BRIEF-‍Richmond Brothers responds to Rockwell Medical's board appointment

* ‍Richmond Brothers Inc issues statement in response to Rockwell Medical Inc's appointment of John Cooper to its board of directors​

Sep 08 2017

BRIEF-Rockwell Medical appoints John Cooper to board

* Rockwell Medical appoints John G. Cooper to board of directors

Sep 07 2017

BRIEF-Richmond Brothers and Mark H. Ravich issue statement on Rockwell Medical Inc

* Richmond Brothers - "Will not settle for anything less than real and meaningful changes" to Rockwell Medical Board Source text for Eikon: Further company coverage:

Aug 30 2017

BRIEF-Richmond Brothers issues public letter to incumbent directors of Rockwell Medical

* Richmond Brothers Inc issues public letter to incumbent directors of Rockwell Medical Inc.

Aug 29 2017

Earnings vs. Estimates